Unlocking how the new Alzheimer's drug lecanemab works
Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be a main driver of the disease. ...
Sep 1, 2023
0
75
